GoodRx Holdings, Inc. (GDRX)

Market Cap	2.15B
Revenue (ttm)	747.21M
Net Income (ttm)	-48.41M
Shares Out	396.87M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	21.60
Dividend	n/a
Ex-Dividend Date	n/a

Volume	338,175
Open	5.37
Previous Close	5.39
Day's Range	5.25 - 5.45
52-Week Range	3.82 - 10.37
Beta	0.91
Analysts	Buy
Price Target	7.87 (+45.07%)
Earnings Date	May 10, 2023

About GDRX

GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutio...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Sep 23, 2020
• Employees: 952
• Stock Exchange: NASDAQ
• Ticker Symbol: GDRX

Financial Performance

In 2022, GDRX's revenue was $766.55 million, an increase of 2.83% compared to the previous year's $745.42 million. Losses were -$32.83 million, 30.0% more than in 2021.

Analyst Forecast

According to 18 analysts, the average rating for GDRX stock is "Buy." The 12-month stock price forecast is $7.87, which is an increase of 45.07% from the latest price.

Price Target

$7.87

(45.07% upside)

Analyst Consensus: Buy